Zecon Pharmaceuticals Private Limited
About Zecon Pharmaceuticals Private Limited
Data last updated:
Zecon Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U93000UP2009PTC036720. Its GSTIN is 09AAACZ3631R1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹12.98 Lakh. It is led by directors including Devraj Kishor and Amit Rai.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 5/47 Vikas Nagar Sector – 5, Lucknow, Uttar Pradesh, India – 226022.
As per the financials filed for FY 2024, the company reported a revenue of ₹65.17 Lakh, a decline of 77% compared to the previous year. For the same year it recorded a net loss of ₹1.68 Cr (net margin -258%) and EBITDA of -₹1.65 Cr (EBITDA margin -253.7%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 30% over five years.
As per MCA filings, the company has open charges of ₹15 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zecon Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address5/47 Vikas Nagar Sector – 5, Lucknow, Uttar Pradesh, India – 226022
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zecon Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zecon Pharmaceuticals is trade. In detail, this covers wholesale trading and retail trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Zecon Pharmaceuticals Private Limited, buy the company report.
Financials of Zecon Pharmaceuticals Private Limited
FY 2024 filings availableZecon Pharmaceuticals Private Limited reported revenue of ₹65.17 Lakh (down 77% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 30% over five years, including a 77% fall in the latest year. EBITDA fell 700% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.65 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.68 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -253.7% | ||||
| Net Profit Margin | -258% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zecon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zecon Pharmaceuticals Private Limited
Zecon Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devraj Kishor Also directs: Raghunandan Manju Pharmaceuticals Private Limited | Director | 04 Feb 2009 | 17 Years 8 Months | Current |
| Amit Rai | Director | 04 Feb 2009 | 17 Years 8 Months | Current |
| Rajeev Kumar Dhondiyal | Director | 04 Feb 2009 | 17 Years 8 Months | Current |
Peer comparison
Zecon Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Victro Pharmaceuticals Private Limited | ₹65.24 Lakh (FY 2025) | -30.0% | New Delhi, Delhi, India | |||
| Akon Pharmaceuticals Private Limited | ₹65.2 Lakh (FY 2024) | 196.0% | Surat, Gujarat, India | |||
| Zecon Pharmaceuticals Private Limitedthis company | ₹65.17 Lakh (FY 2024) | -₹1.68 Cr | -258% | -77.0% | Lucknow, Uttar Pradesh, India | |
| Aironax Pharmaceuticals Private Limited | ₹65.15 Lakh (FY 2025) | 138.0% | Vadodara, Gujarat, India | |||
| Almonds Pharmaceuticals Private Limited | ₹65.07 Lakh (FY 2021) | 5.0% | Kolar, Karnataka, India | |||
| Gopal Pharma Private Limited | ₹65.03 Lakh (FY 2024) | -12.0% | Uttar Pradesh, India | |||
| SMS Meditech India Private Limited | ₹65.03 Lakh (FY 2018) | 188.0% | Ghaziabad, Uttar Pradesh, India | |||
| Grebitor Healthcare Private Limited | ₹64.77 Lakh (FY 2025) | 35.0% | Pune, Maharashtra, India |
To see the full peer comparison of Zecon Pharmaceuticals Private Limited, buy the company report.
Auditor
Zecon Pharmaceuticals Private Limited is audited by R J C P SUBHASH MISRA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R J C P SUBHASH MISRA & CO | FY 2018 | 007415C |
Shareholding
The shareholding of Zecon Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Zecon Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jun 2014 | 10507217 | Union Bank of India | ₹5 Lakh | Open | |
| 02 Jun 2014 | 10507564 | Union Bank of India | ₹5 Lakh | Open | |
| 02 Jun 2014 | 10507568 | Union Bank of India | ₹5 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Zecon Pharmaceuticals Private Limited has 2 court cases on record: 1 filed by Zecon Pharmaceuticals, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Allahabad | Company petition | Filed against the company by individuals | Disposed |
| Allahabad High Court | Writ petition | Filed by the company against State of U.P. Thru.Addl. Chief Secy. Food Safety and Drug Administration and 3 Others | Disposed |
To see the full case history of Zecon Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zecon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zecon Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACZ3631R1ZP | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zecon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zecon Pharmaceuticals Private Limited has 4 board changes on record since 2009: 3 appointments and 1 cessation. The latest: Ajit Jain ceased to be Director on 06 Dec 2012.
Frequently asked questions
Zecon Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 February 2009 (17+ years old) and is registered under CIN U93000UP2009PTC036720.
Zecon Pharmaceuticals has 3 current directors:
- Devraj Kishor - Director
- Amit Rai - Director
- Rajeev Kumar Dhondiyal - Director
The latest financial statements of Zecon Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Zecon Pharmaceuticals is 09AAACZ3631R1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Zecon Pharmaceuticals is U93000UP2009PTC036720. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zecon Pharmaceuticals has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the high courts.
Zecon Pharmaceuticals was incorporated on 04 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Zecon Pharmaceuticals by revenue are Victro Pharmaceuticals Private Limited, Akon Pharmaceuticals Private Limited, Aironax Pharmaceuticals Private Limited, Almonds Pharmaceuticals Private Limited, Gopal Pharma Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ajit Jain ceased to be Director on 06 Dec 2012. Amit Rai was appointed as Director on 04 Feb 2009. Devraj Kishor was appointed as Director on 04 Feb 2009. Zecon Pharmaceuticals has 4 board changes on record in total.
The registered office of Zecon Pharmaceuticals is at 547 Vikas Nagar Sector – 5, Lucknow, Uttar Pradesh, India – 226022.
Zecon Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.